An open‐label study to explore the optimal design of CYP3A drug-drug interaction clinical trials in healthy Chinese people

Abstract A drug-drug interaction (DDI) trial of cytochrome P450 3A (CYP3A) is a necessary part of early‐phase trials of drugs mainly metabolized by this enzyme, but CYP3A DDI clinical trials do not have a standard design, especially for Chinese people. We aimed to offer specific recommendations for...

詳細記述

保存先:
書誌詳細
主要な著者: Jingcheng Chen (著者), Jiangshuo Li (著者), Jingxuan Wu (著者), Yuqin Song (著者), Lijun Li (著者), Jianxiong Zhang (著者), Ruihua Dong (著者)
フォーマット: 図書
出版事項: Wiley, 2024-08-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可